EU New Drug Approvals Hit Record High
Total Includes Seven COVID-19 Products
Executive Summary
Chaos wrought by the ongoing coronavirus pandemic. A heavy workload and continuing resource constraints at the European Medicines Agency. Nonetheless, a record number of novel drugs and vaccines were cleared for marketing in the EU last year.